Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol
Cohort design, covariates, and outcomes This retrospective, propensity-score-matched cohort study included obese patients (BMI 27 kg/m) initiating Tirzepatide, Semaglutide, Phentermine/Topiramate, Naltrexone/Bupropion, or Phentermine from November 1, 2023, through April 31, 2025
Designed to deliver the benefits of GLP-1 medications in a convenient, needle-free format, this innovative format reimagines how individuals approach GLP-1 programs in the United States
These changes can help patients further facilitate their weight loss goals by making it easier to implement sustainable lifestyle interventions such as exercising more frequently
Moreover, although inspections in 2021 and 2022 were far less numerous than in non-pandemic years, investigators were prompt in issuing letters